3 completed, 2 unknown, 1 recruiting. 2 Phase 1, 2 Phase 3, 1 Early Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Early Phase 1 | 1 | Unknown 1 |
| Phase 4 | 1 | Completed 1 |
Follow Gemifloxacin: new trials by email Literature Review of Gemifloxacin trials Research Report on Gemifloxacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EFFECTS OF MOXIFLOXACIN AND GEMIFLOXACIN ON BLOOD GLUCOSE AND ECG MORPHOLOGY OF EUGLYCEMICS:A CLINICAL STUDY Moxifloxacin 400mg, Gemifloxacin 320 MG - Blood Glucose, Low, Hypoglycemia | Phase 1 | Completed | Shaheed Benazir Bhutto University Sheringal Dir Upper | 25 | 2021-03-01 | 2023-04-12 |
| Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis Cefotaxime, Gemifloxacin - Spontaneous Bacterial Peritonitis | Phase 3 | Recruiting | Tanta University | 60 | 2018-12-01 | 2019-11-19 |
| Comparison Between Rifampicin and Gemifloxacin and Ciprofloxacin in Treatment of Rhinoscleroma Gemifloxacin, Ciprofloxacin, Rifampicin - Rhinoscleroma | Early Phase 1 | Unknown | Assiut University | 60 | 2018-02-01 | 2018-02-13 |
| Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori Infection Gemifloxacin-based triple therapy, Standard triple therapy - Helicobacter Pylori Infection | Phase 3 | Unknown | Samsung Medical Center | 252 | 2015-02-01 | 2015-02-24 |
| Efficacy of Combination Therapies for Gonorrhea Treatment Azithromycin, Gentamicin, Gemifloxacin - Gonorrhoea | Phase 4 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 614 | 2010-06-01 | 2015-08-19 |
| Phase I Trial for Pharmacokinetic Characteristics of Factive 200mg Intravenous Formulation (Gemifloxacin 200mg) With Factive 320mg Tablet Formulation (Gemifloxacin 320mg) Factive® Tab / Factive IV - Infectious Diseases | Phase 1 | Completed | LG Life Sciences | 16 | 2006-01-01 | 2013-06-17 |
Communicable Diseases (1) · Gonorrhea (1) · Hypoglycemia (1) · Rhinoscleroma (1)
Assiut University (1) · LG Life Sciences (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Samsung Medical Center (1) · Shaheed Benazir Bhutto University Sheringal Dir Upper (1) · Tanta University (1)
Egypt (2) · South Korea (2) · Pakistan (1) · United States (1)
Abid Ullah, Ph.D Scholar (1) · Hala Shaaban El Gendy, Msc (1) · Hyuk Lee, MD (1) · Osama El Sayed Negm, Prof. (1) · Sherief Abd-Elsalam, Ass. Prof. (1)
PMID 10798549, PMID 11448564, PMID 14557966, PMID 17192170, PMID 19146007, PMID 21410904, PMID 21453653, PMID 2246576, PMID 25031289, PMID 26339415, PMID 35203750, PMID 3734600, PMID 8100894